Overview

Bioequivalence - Duodart Against Avodart & Omnic

Status:
Completed
Trial end date:
2012-12-05
Target enrollment:
Participant gender:
Summary
Open-label, randomized, single dose, two-treatment, two-way crossover study
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Dutasteride
Tamsulosin